It has been reported that CD40 signaling induces malignant cell death in many cancer types, including renal cell carcinoma [29], urothelial cell carcinoma [30], ovarian carcinoma [31, 32], cervical carcinoma [33] and bladder carcinoma [34]. This evidence concerns the gene CD40 and cancer.